UnitedHealth Group Inc (NYSE:UNH) Shares Sold by Vivaldi Capital Management LLC
Vivaldi Capital Management LLC decreased its position in UnitedHealth Group Inc (NYSE:UNH) by 39.5% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,580 shares of the healthcare conglomerate’s stock after selling 3,647 shares during the quarter. Vivaldi Capital Management LLC’s holdings in UnitedHealth Group were worth $1,362,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently modified their holdings of UNH. Garrison Point Advisors LLC raised its stake in UnitedHealth Group by 1.2% during the 2nd quarter. Garrison Point Advisors LLC now owns 3,486 shares of the healthcare conglomerate’s stock valued at $851,000 after acquiring an additional 40 shares in the last quarter. Integrated Investment Consultants LLC raised its stake in UnitedHealth Group by 3.9% during the 2nd quarter. Integrated Investment Consultants LLC now owns 1,131 shares of the healthcare conglomerate’s stock valued at $276,000 after acquiring an additional 42 shares in the last quarter. Meridian Financial Partners LLC raised its stake in UnitedHealth Group by 2.7% during the 2nd quarter. Meridian Financial Partners LLC now owns 1,633 shares of the healthcare conglomerate’s stock valued at $403,000 after acquiring an additional 43 shares in the last quarter. 1ST Source Bank raised its stake in UnitedHealth Group by 3.0% during the 2nd quarter. 1ST Source Bank now owns 1,569 shares of the healthcare conglomerate’s stock valued at $383,000 after acquiring an additional 45 shares in the last quarter. Finally, Alera Investment Advisors LLC raised its stake in UnitedHealth Group by 2.7% during the 2nd quarter. Alera Investment Advisors LLC now owns 1,689 shares of the healthcare conglomerate’s stock valued at $412,000 after acquiring an additional 45 shares in the last quarter. Institutional investors own 85.66% of the company’s stock.
In other news, Director William C. Ballard, Jr. sold 12,000 shares of UnitedHealth Group stock in a transaction on Tuesday, July 23rd. The stock was sold at an average price of $255.31, for a total transaction of $3,063,720.00. Following the transaction, the director now owns 61,309 shares in the company, valued at $15,652,800.79. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Timothy Patrick Flynn purchased 2,000 shares of the stock in a transaction dated Wednesday, August 28th. The shares were acquired at an average price of $227.55 per share, for a total transaction of $455,100.00. Following the acquisition, the director now directly owns 5,524 shares of the company’s stock, valued at approximately $1,256,986.20. The disclosure for this purchase can be found here. Insiders sold a total of 21,500 shares of company stock worth $5,340,620 over the last 90 days. Insiders own 0.87% of the company’s stock.
UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, July 18th. The healthcare conglomerate reported $3.60 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $3.46 by $0.14. The business had revenue of $60.60 billion for the quarter, compared to analysts’ expectations of $60.59 billion. UnitedHealth Group had a return on equity of 25.20% and a net margin of 5.51%. The company’s quarterly revenue was up 8.0% on a year-over-year basis. During the same period in the previous year, the firm posted $3.14 EPS. On average, research analysts expect that UnitedHealth Group Inc will post 14.84 EPS for the current year.
The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Investors of record on Monday, September 16th will be issued a $1.08 dividend. This represents a $4.32 dividend on an annualized basis and a dividend yield of 1.86%. The ex-dividend date of this dividend is Friday, September 13th. UnitedHealth Group’s payout ratio is 33.54%.
A number of analysts have recently commented on UNH shares. Raymond James boosted their price objective on UnitedHealth Group from $265.00 to $300.00 and gave the stock a “buy” rating in a research note on Friday, July 19th. ValuEngine downgraded UnitedHealth Group from a “hold” rating to a “sell” rating in a research note on Thursday, September 5th. Deutsche Bank started coverage on UnitedHealth Group in a research note on Thursday, September 12th. They issued a “hold” rating and a $263.00 price objective on the stock. Zacks Investment Research raised UnitedHealth Group from a “sell” rating to a “buy” rating and set a $269.00 price objective on the stock in a research note on Monday, July 22nd. Finally, Cantor Fitzgerald set a $310.00 price objective on UnitedHealth Group and gave the stock a “buy” rating in a research note on Friday, July 19th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and seventeen have assigned a buy rating to the stock. UnitedHealth Group has an average rating of “Buy” and a consensus price target of $291.61.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Story: Why do commodities matter?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.